These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9006937

  • 41. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.
    Schmitz F, Pratt DS, Wu MJ, Kolakowski LF, Beinborn M, Kopin AS.
    Mol Pharmacol; 1996 Aug; 50(2):436-41. PubMed ID: 8700154
    [Abstract] [Full Text] [Related]

  • 42. Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180.
    Sato S, Stark HA, Martinez J, Beaven MA, Jensen RT, Gardner JD.
    Am J Physiol; 1989 Aug; 257(2 Pt 1):G202-9. PubMed ID: 2475030
    [Abstract] [Full Text] [Related]

  • 43. The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor.
    Gouldson P, Legoux P, Carillon C, Delpech B, Le Fur G, Ferrara P, Shire D.
    Eur J Pharmacol; 2000 Jul 21; 400(2-3):185-94. PubMed ID: 10988332
    [Abstract] [Full Text] [Related]

  • 44. Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.
    Lallement JC, Oiry C, Lima-Leite AC, Lignon MF, Fulcrand P, Galleyrand JC, Martinez J.
    Eur J Pharmacol; 1995 Jul 18; 290(2):61-7. PubMed ID: 8575534
    [Abstract] [Full Text] [Related]

  • 45. Mapping of ligand binding sites of the cholecystokinin-B/gastrin receptor with lipo-gastrin peptides and molecular modeling.
    Lutz J, Romano-Götsch R, Escrieut C, Fourmy D, Mathä B, Müller G, Kessler H, Moroder L.
    Biopolymers; 1997 Jun 18; 41(7):799-817. PubMed ID: 9128441
    [Abstract] [Full Text] [Related]

  • 46. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors.
    Schäfer U, Harhammer R, Boomgaarden M, Sohr R, Ott T, Henklein P, Repke H.
    J Neurochem; 1994 Apr 18; 62(4):1426-31. PubMed ID: 8133271
    [Abstract] [Full Text] [Related]

  • 47. Differences in receptor binding and stability to enzymatic digestion between CCK-8 and CCK-58.
    Reeve JR, McVey DC, Bunnett NW, Solomon TE, Keire DA, Ho FJ, Davis MT, Lee TD, Shively JE, Vigna SR.
    Pancreas; 2002 Oct 18; 25(3):e50-5. PubMed ID: 12370550
    [Abstract] [Full Text] [Related]

  • 48. Mutational analysis of the putative devazepide binding site of the CCK(A) receptor.
    Smeets RL, IJzerman AP, Hermsen HP, Ophorst OJ, Van Emst-de Vries SE, De Pont JJ, Willems PH.
    Eur J Pharmacol; 1997 Apr 23; 325(1):93-9. PubMed ID: 9151944
    [Abstract] [Full Text] [Related]

  • 49. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
    Harikumar KG, Pinon DI, Wessels WS, Dawson ES, Lybrand TP, Prendergast FG, Miller LJ.
    Mol Pharmacol; 2004 Jan 23; 65(1):28-35. PubMed ID: 14722234
    [Abstract] [Full Text] [Related]

  • 50. The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states.
    Molero X, Miller LJ.
    Mol Pharmacol; 1991 Feb 23; 39(2):150-6. PubMed ID: 1899903
    [Abstract] [Full Text] [Related]

  • 51. Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy.
    Pellegrini M, Mierke DF.
    Biochemistry; 1999 Nov 09; 38(45):14775-83. PubMed ID: 10555959
    [Abstract] [Full Text] [Related]

  • 52. Identification of a domain in the carboxy terminus of CCK receptor that affects its intracellular trafficking.
    Go WY, Holicky EL, Hadac EM, Rao RV, Miller LJ.
    Am J Physiol; 1998 Jul 09; 275(1):G56-62. PubMed ID: 9655684
    [Abstract] [Full Text] [Related]

  • 53. Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites.
    Moran TH, Kornbluh R, Moore K, Schwartz GJ.
    Regul Pept; 1994 Aug 04; 52(3):165-72. PubMed ID: 7800848
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP.
    J Med Chem; 1997 Feb 28; 40(5):647-58. PubMed ID: 9057851
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
    Oiry C, Galleyrand JC, Lima-Leite AC, Fulcrand P, Martinez J.
    Eur J Pharmacol; 1995 Dec 29; 294(2-3):511-9. PubMed ID: 8750713
    [Abstract] [Full Text] [Related]

  • 60. Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling.
    Dong M, Lam PC, Pinon DI, Abagyan R, Miller LJ.
    Biochemistry; 2009 Jun 16; 48(23):5303-12. PubMed ID: 19441839
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.